Background: Previous genome-wide association study (GWAS) of polycystic ovary syndrome (PCOS) in Han Chinese population has found that SNPs in LPP gene were nominally significant in PCOS patients (P around 10E-05). Replication of the GWAS was applied to further confirm the relationship between LPP gene and PCOS.
Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder affecting 6-8% reproductive-aged women [1] . It is a heterogeneous disease characterized by oligoovulation and/or anovulation, clinical and/or biochemical hyperandrogenism and polycystic ovaries on ultrasound [2] . Women with PCOS have a high risk suffering from metabolic syndrome [3] , type 2 diabetes (T2D) and cardiovascular diseases [4, 5] . Insulin resistance, present in perhaps 70% of women with PCOS [6, 7] , may play an important role in the long-term complications of PCOS. Previously we conducted a genome-wide association study (GWAS) on PCOS in Han Chinese, including single nucleotide polymorphisms (SNPs) with P value less than 10E-06 were replicated, in which three susceptibility loci were confirmed [8] . However, other loci with P value around 10E-05 may also pose potential risks to PCOS and need replication study to confirm the association.
In our GWAS data [8] , a pile of SNPs with P value from 10E-04 to 10E-05 were found within gene Lim domain containing preferred translocation partner in lipoma (LPP) on chromosome 3q28 (Table S1 ). The LPP gene contains 10 exons and spans a genomic region of more than 400 kb. Studies suggested that LPP was a substrate of the protein-tyrosine-phosphatase 1 B (PTP1B) [9] , which is a negative regulator of insulin signaling pathway and plays important roles in the pathogenesis of insulin resistance [10] . Insulin resistance is one of the most important metabolic disorders in women with PCOS. Combining our GWAS data, further replication study is needed to confirm the association of LPP gene and PCOS.
To determine the relationship of LPP and PCOS, three SNPs rs715790 (T/C), rs4449306 (C/A) and rs6782041(C/T) in LPP were genotyped in an additionally independent-sample set of 1132 PCOS cases and 1142 controls. Meta-analysis was performed to combine our GWAS data and the replication data. 
Materials and Methods

Subjects
Measures
The level of serum testosterone (T) of all subjects were measured by a chemiluminescent analyzer (Beckman Access Health Company, Chaska, MN, USA). 75 g oral glucose tolerance test (OGTT) was carried out for PCOS patients (AU640 automatic biochemistry analyzer; Olympus Company, Hamburg, Germany). The glucose levels and insulin levels at 0 min and 120 min were evaluated. Insulin resistance was estimated by the homeostasis model assessment (HOMA-IR) method according to the formula: fasting glucose (mmol/L) * fasting insulin (mIU/L)/22.5.
SNP Selection
SNPs of LPP selected for replication were in accordance with the following criteria: SNPs that exist in the Affymetrix 6.0 chip, can stand for a block; minor allele frequency (MAF) .5% in the Han Chinese population; in the linkage disequilibrium test, SNPs with r 2 ,0.8 were selected. All selected SNPs were statistically different (P,10E-04) in our previous GWA study (Table S1 ) [11] . SNPs rs715790 (T/C, P GWAS = 6.97E-05), rs4449306 (C/A, P GWAS = 9.6E-04) and rs6782041 (C/T, P GWAS = 9.13E-05) in different blocks of LPP gene were selected for replication study (Fig. S1 ).
Genotyping
DNA was extracted from EDTA anticoagulated blood by a QIAamp DNA mini kit (QIAGEN, Hiden, Germany). Three SNPs were analyzed by TaqMan-MGB probe assay (Invitrogen trading, Shanghai) (Table S2 ). Taqman-MGB fluorescence quantitative PCR was performed on the Light Cycle system (Roche480). Reaction conditions were carried out by initial denaturation at 95uC for 10 min, followed by 45 cycles of denaturation at 95uC for 15 s, annealing at 58uC for 30 s, extension at 72uC for 30 s.
Statistical Analysis
Clinical characteristics of cases and controls were expressed as means6SD. To evaluate the relationship between each SNPs, pairwise linkage-disequilibrium (LD) (D9 and correlation coefficients r 2 ) were calculated by Haploview. Chi-square test was performed to compare allele frequencies of rs715790, rs4449306 and rs6782041. Combing our previous GWAS data and the present data, meta-analysis was performed using Review Manager 5.1 software, with both fixed and random effects models. Data was presented as odds ratio (OR) and 95% confidence interval (95%CI).
Genotypes of each SNPs were analyzed by additive (+/+ vs. +/ 2 vs. 2/2), dominant (+/+ plus +/2 vs. 2/2) and recessive (+/ + vs. +/2 plus 2/2). Genotype-phenotype correlation of PCOS was analyzed by independent sample T test.
In phenotype analysis, Chi-square test, independent T test were analysed, and logistic regression analysis used for age and BMI adjustment by SPSS16.0 software (SPSS Inc., Chicago, IL, USA). Statistic significant level was defined as P,0.05.
Results
Clinical characteristics of PCOS cases and controls are summarized in Table 1 . The PCOS group was younger than the control group (P,0.001). And PCOS group had higher body mass index (P,0.001) than control group. Thus, age and BMI were adjusted in the subsequent analysis.
Analyzed by Haploview, Hardy-Weinberg equilibrium tested allele frequencies of the three SNPs were in accordance both in PCOS cases and controls. There were little linkage between rs715790 and rs4449306 (D9 = 0.142, r 2 = 0.018), rs715790 and rs6782041 (D9 = 0.372, r 2 = 0.114), rs4449306 and rs6782041 (D9 = 0.668, r 2 = 0.397). The allele frequencies of rs715790, rs4449306 and rs6782041 were presented in Table 2 . In the PCOS group, allele frequency of rs715790 was significantly higher than the control group (P = 0.021, OR = 1.151, 95%CI = 1.021-1.297), even adjusted by age and BMI using logistic regression test (P = 0.024). However, statistical difference of allele frequency was not found in rs4449306 (P = 0.057, OR = 1.122, 95%CI = 0.997-1.262), and rs6782041 (P = 0.114, OR = 1.098, 95%CI = 0.978-1.234). Furthermore, combining previous GWAS data to the present data by meta-analysis (Table 2 ), significant differences were found in all three SNPs, rs715790 (P meta = 1.89E-05, OR = 1.23, 95%CI = 1.12-1.34), rs4449306 (P meta = 3.0E-04, OR = 1.18, 95%CI = 1.08-1.29), and rs6782041 (P meta = 2.0E-04, OR = 1.19, 95%CI = 1.09-1.30).
Genotype of the three SNPs were analyzed by chi-square test (Table 3 ). In the additive model, significant difference was discovered only in rs715790 (P = 0.023). In dominant model, significant difference was found in all three SNPs, rs715790 (P = 0.006), rs4449306 (P = 0.02) and rs6782041 (P = 0.03). However, there was no significant difference in recessive model. Of all three models, the dominant model was most effective for genotype analysis.
The dominant model of genotype was thus used to evaluate the clinical characteristics in PCOS patients. In rs715790 (Table 4) , there was no statistical differences for T levels between risk allele group and non-risk allele group. After adjusted by BMI impact, the glucose levels and insulin levels showed no significant differences between risk allele group and non-risk allele group. There were no differences in HOMA-IR between the two groups.
Discussion
In our previous GWA study [8] , several loci with P value less than 10E-06 have been identified; However, other loci with P value around 10E-05 are also worthy of investigation, just as YAP1 gene, which we previously confirmed as another susceptibility gene for PCOS [11] . In this study, we performed a replication study of SNPs in LPP gene, and confirmed the plausibility that LPP could be a new candidate gene for PCOS.
Three SNPs were carefully selected and one of them, rs715790, was identified to be significantly associated with PCOS. In GWAS data, rs715790 (P GWAS = 6.97E-05) was significantly different between PCOS and controls. Meta-analysis of previous GWA study and the replication data still showed significant difference (P meta = 1.89E-05) in allele frequency. The other selected SNPs rs4449306 and rs6782041 were not replicated, but remain statistically different in meta-analysis study.
LPP encodes Lim domain proteins subfamily that are characterized by an N-terminal proline rich region and three C-terminal Lim domains. LPP, as a substrate of PTP1B, may participates in insulin signaling pathway through binding to PTP1B. Binding of insulin to its receptor evokes autophosphorylation of the receptor on tyrosines in the kinase regulatory domain, activating the insulin receptor tyrosine kinase, which phosphorylates the various insulin receptor substrate proteins that trigger the downstream of insulin signaling events [12] . In the insulin signaling pathway, acting as a negative regulator, PTP1B could dephosphorylate the activated insulin receptor [10] . Studies showed that, in obesity, PTP1B expression was increased, which might worsen insulin resistance in those people [13] . PCOS cases have more serious insulin resistance than age-matched controls but independent of BMI [14, 15] . Thus, whether and how LPP functions in this pathway still needs further and extensive studies. Here, LPP was confirmed to be a plausible candidate for PCOS, however, no association was found between characteristic insulin resistance and LPP gene. The possible reason is that our enrolled subjects were of reproductive age (the average age is 28.54), and at that time few of them suffered from insulin resistance or type 2 diabetes, and this may cause type II error. Overall, this study indicates that LPP is a novel candidate for PCOS. Nevertheless, further studies are warranted to replicate the association patterns in larger cohorts with different genetic background. Functional studies should be considered to explore more meaningful insights on the role of LPP gene towards PCOS. 
Supporting Information
